Skip to main content
. 2022 Jul 22;20(1):18–20. doi: 10.1002/cld.1232

TABLE 1.

Liquid biopsy technologies

Biomarker Description Isolation techniques
Circulating tumor cells (CTCs) Cells released from sites of primary and metastatic cancer into the bloodstream
  1. Size‐based filtration of CTCs
  2. Immunofluorescent staining of CTCs using established epithelial or tumor cell surface markers
  3. Antibody targeting of white blood cells for removal, followed by collection of untagged CTCs
Cell‐free DNA (cfDNA) Nucleic acid shed into circulation during cellular necrosis or apoptosis; a subset of cfDNA is derived from tumor cells, i.e. circulating tumor DNA (ctDNA) Centrifugation for removal of cells, followed by plasma extraction of cfDNA
Extracellular vesicles (EVs) Cell membrane‐derived particles, including apoptotic bodies, microvesicles and exosomes, that contain molecular cargoes specific to the origin cell and have important roles in cell‐to‐cell communication Ultracentrifugation, which isolates EVs based on size and density